amyloid-beta – Talk Bio

Actionable Insights Powered by AI

FDA Approves Monthly Maintenance Dosing for Eisai and Biogen’s Alzheimer’s Drug Leqembi

3 months ago talkbio0Tagged Alzheimer 's disease, amyloid-beta, Approved, Biogen, dosing, Eisai, Leqembi, Maintenance, Mental deterioration, monthly, United States Food and Drug Administration

Leqembi, Alzheimer’s disease, FDA approval, monthly maintenance dosing, Eisai, Biogen, amyloid-beta, cognitive decline

Anavex’s New Analysis of Alzheimer’s Pill Shows Mixed Results

9 months ago talkbio0Tagged Alzheimer 's disease, amyloid-beta, Anavex, Blarcamesine, Cerebral atrophy, EMA Approval, Mental deterioration, Nerve Degeneration, Phase IIb/III trial, Treatment Effectiveness

Anavex, Alzheimer’s disease, blarcamesine, Phase IIb/III trial, clinical efficacy, neurodegeneration, cognitive decline, amyloid-beta, brain atrophy, EMA approval.